Your browser doesn't support javascript.
loading
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.
Sharma, Nikita S; Gupta, Vineet K; Garrido, Vanessa T; Hadad, Roey; Durden, Brittany C; Kesh, Kousik; Giri, Bhuwan; Ferrantella, Anthony; Dudeja, Vikas; Saluja, Ashok; Banerjee, Sulagna.
J Clin Invest ; 130(1): 451-465, 2020 01 02.
Article in En | MEDLINE | ID: mdl-31613799
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Diazooxonorleucine / Programmed Cell Death 1 Receptor / Hexosamines / Neoplasm Proteins Limits: Animals / Female / Humans Language: En Journal: J Clin Invest Year: 2020 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Diazooxonorleucine / Programmed Cell Death 1 Receptor / Hexosamines / Neoplasm Proteins Limits: Animals / Female / Humans Language: En Journal: J Clin Invest Year: 2020 Document type: Article Country of publication: Estados Unidos